Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Developing monoclonal antibody against multiple targets associated with the production and use of vasopressin in cancer.
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |